A leading Spanish medical cannabis company, recognized for its expertise in premium genetics, craft cannabis cultivation, and research & development, is looking for a strategic equity partner to create new growth and expansion opportunities.
- Innovative Medical Cannabis Producer: Authorized by the Spanish Health Agency and Medical Devices (AEMPS) for cultivation and research, with commercial production licensing forthcoming.
- Focus on Premium Genetics: Specializes in selecting trending genetics, cultivating top-quality, non-irradiated medical cannabis flowers, and maintaining EU-GMP standards for hang-drying and semi-hand trimming.
- Strategic Location: Located in Barcelona's industrial hub, this fully operational facility spans two floors, covering ~2,500 m² (~26,000 sq. ft.) with 600 m² dedicated to cultivation and 300 m² to EU-GMP processing, offering substantial room for expansion, including the potential for vertical farming.
- EU-GMP Production Ready: The company has a pre-agreement to produce EU-GMP cannabis dry flowers as Active Pharmaceutical Ingredients (APIs) and is in talks with additional partners to expand production.
- Near-Term Licensing Goals: Aiming to secure the EU-GMP Certificate and full Commercial License by Q4 2023.
- Future Growth: Plans include registering proprietary brands, importing clones, expanding craft cannabis production with premium genetics, and exploring additional product categories.
- Partnership Opportunity: Ideal for an experienced partner, particularly from Canada or other established LPs, to support the expansion and market success of this pioneering Spanish cannabis venture.
